FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

1879411000001106: Zantac 300mg effervescent tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
25217301000001111 Zantac 300mg effervescent tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
58142401000001112 Zantac 300mg effervescent tablets (GlaxoSmithKline UK Ltd) 30 tablet 2 x 15 tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zantac 300mg effervescent tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zantac 300mg effervescent tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zantac 300mg effervescent tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets Is a Ranitidine 300mg effervescent tablets 30 tablet true Inferred relationship Existential restriction modifier
Zantac 300mg effervescent tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets Is pack of Zantac 300mg effervescent tablets (GlaxoSmithKline) false Inferred relationship Existential restriction modifier
Zantac 300mg effervescent tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free false Inferred relationship Existential restriction modifier
Zantac 300mg effervescent tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Zantac 300mg effervescent tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Zantac 300mg effervescent tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets Has active ingredient Ranitidine hydrochloride false Inferred relationship Existential restriction modifier
Zantac 300mg effervescent tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets Has active ingredient Ranitidine false Inferred relationship Existential restriction modifier
Zantac 300mg effervescent tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets Has excipient Aspartame false Inferred relationship Existential restriction modifier
Zantac 300mg effervescent tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Zantac 300mg effervescent tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Zantac 300mg effervescent tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zantac 300mg effervescent tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Zantac 300mg effervescent tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Zantac 300mg effervescent tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets Has AMP Zantac 300mg effervescent tablets (GlaxoSmithKline) true Inferred relationship Existential restriction modifier
Zantac 300mg effervescent tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ranitidine true Inferred relationship Existential restriction modifier
Zantac 300mg effervescent tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets Has specific active ingredient Ranitidine hydrochloride true Inferred relationship Existential restriction modifier
Zantac 300mg effervescent tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets Has dispensed dose form Effervescent tablet false Inferred relationship Existential restriction modifier
Zantac 300mg effervescent tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Zantac 300mg effervescent tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Zantac 300mg effervescent tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets Has basis of strength substance Ranitidine true Inferred relationship Existential restriction modifier
Zantac 300mg effervescent tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets Has dispensed dose form Conventional release effervescent oral tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start